A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity.

This study was undertaken to determine the highly sensitive method for detecting tumour lymphatic vessels in all the fields of each slide (LV), lymphatic microvessel density (LMVD) and lymphatic vessel invasion (LVI) and to compare them with other prognostic parameters using immunohistochemical stai...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Kato, T, Prevo, R, Steers, G, Roberts, H, Leek, R, Kimura, T, Kameoka, S, Nishikawa, T, Kobayashi, M, Jackson, D, Harris, A, Gatter, K, Pezzella, F
Formato:	Journal article
Idioma:	English
Publicado em:	2005

Registos relacionados

LYVE-1, the lymphatic system and tumor lymphangiogenesis.
Por: Jackson, D, et al.
Publicado em: (2001)

Basement membrane protein distribution in LYVE-1-immunoreactive lymphatic vessels of normal tissues and ovarian carcinomas.
Por: Vainionpää, N, et al.
Publicado em: (2007)

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium.
Por: Prevo, R, et al.
Publicado em: (2001)

The distribution of lymphatic vessels in lymphomas compared with reactive lymphadenopathy.
Por: Pillai, G, et al.
Publicado em: (2003)

Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1.
Por: Johnson, L, et al.
Publicado em: (2007)

Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1.
Por: Gale, N, et al.
Publicado em: (2007)

Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.
Por: Kato, T, et al.
Publicado em: (2007)

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Por: Cursiefen, C, et al.
Publicado em: (2002)

Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.
Por: Jackson, D
Publicado em: (2004)

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.
Por: Bono, P, et al.
Publicado em: (2004)

Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor (LYVE-1) by ocular surface cells.
Por: Chen, L, et al.
Publicado em: (2004)

The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1.
Por: Jackson, D
Publicado em: (2003)

The cortical actin network regulates avidity-dependent binding of hyaluronan by the Lymphatic Vessel Endothelial receptor LYVE-1
Por: Stanly, TA, et al.
Publicado em: (2020)

Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Por: Trojan, L, et al.
Publicado em: (2004)

Lymphatic and blood vessels in parathyroid tumors: Immunohistochemical study with LYVE-1 and von Willebrand factor
Por: Tatsuo Tomita
Publicado em: (2024-08-01)

Binding of hyaluronan to the native lymphatic vessel endothelial receptor LYVE-1 is critically dependent on receptor clustering and hyaluronan organization
Por: Lawrance, W, et al.
Publicado em: (2016)

Hyaluronan in the lymphatics: The key role of the hyaluronan receptor LYVE-1 in leucocyte trafficking
Por: Jackson, D
Publicado em: (2018)

DOES PERITUMORAL LYVE-1 IMMUNOREACTIVITY PREDICT THE SENTINEL LYMPH NODE METASTASIS?
Por: Hilal Koçdor, et al.
Publicado em: (2006-01-01)

High LYVE-1 positive lymphatic vessel numbers are associated with axillary lymph node metastases and poor outcome in breast cancer.
Por: Bono, P, et al.
Publicado em: (2004)

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.
Por: Koukourakis, M, et al.
Publicado em: (2005)

A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium.
Por: Nightingale, T, et al.
Publicado em: (2009)

The expression of the lymphatic endothelial cell marker LYVE-1 in benign and malignant vascular tumours
Por: Edwards, J, et al.
Publicado em: (2003)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
Por: Banerji, S, et al.
Publicado em: (2016)

Homodimerisation of the lymph vessel endothelial receptor LYVE-1 through a redox-labile disulfide is critical for hyaluronan binding in lymphatic endothelium
Por: Banerji, S, et al.
Publicado em: (2016)

Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule.
Por: Tarik Attout, et al.
Publicado em: (2009-12-01)

Distribution of lymphatic vessels in normal and arthritic human synovial tissues.
Por: Xu, H, et al.
Publicado em: (2003)

Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.
Por: Banerji, S, et al.
Publicado em: (2010)

Novel erectile analyses revealed augmentable penile Lyve‐1, the lymphatic marker, expression
Por: Kota Fujimoto, et al.
Publicado em: (2024-01-01)

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
Por: Williams, C, et al.
Publicado em: (2003)

Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1: correlation with pathologic parameters and clinical outcome.
Por: Heinzelbecker, J, et al.
Publicado em: (2013)

Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1
Por: Johnson, L, et al.
Publicado em: (2017)

LYVE-1 expression in the endothelium of newly formed vessels of carotid atherosclerotic plaque
Por: Anna N. Evdokimenko, et al.
Publicado em: (2020-09-01)

Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles
Por: Guo Q, et al.
Publicado em: (2013-06-01)

MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis
Por: Hoi Leong Xavier Wong, et al.
Publicado em: (2016-03-01)

FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake
Por: Shikshya Shrestha, et al.
Publicado em: (2020-07-01)

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.
Por: Leek, R, et al.
Publicado em: (1994)

LYVE-1 and hyaluronan - a molecular velcro
Por: Lawrance, W
Publicado em: (2013)

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.
Por: Stacker, SA, et al.
Publicado em: (2001)

Pre-collecting lymphatic vessels form detours following obstruction of lymphatic flow and function as collecting lymphatic vessels.
Por: Kimi Asano, et al.
Publicado em: (2020-01-01)

Deciphering the heterogeneity of the Lyve1+ perivascular macrophages in the mouse brain
Por: C. Siret, et al.
Publicado em: (2022-11-01)